Marshall Wace
LMDXW

Marshall Wace’s LumiraDx Limited Warrant LMDXW Stock Holding History

Marshall Wace’s Portfolio LMDXW Stock Details LMDXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-168,400
Closed -$172K – 3589
2022
Q3 		$172K Sell
168,400
-64,467
-28% -$21.4K ﹤0.01% 3120
2022
Q2 		$621K Sell
232,867
-20,559
-8% -$17.8K ﹤0.01% 2691
2022
Q1 		$1.52M Hold
253,426
– – ﹤0.01% 2215
2021
Q4 		$2.25M Hold
253,426
– – ﹤0.01% 1969
2021
Q3 		$2.1M Buy
+253,426
New +$294K 0.01% 1508

Other funds holding LMDXW

CH
CVS Health Woonsocket, Rhode Island $212M AUM 19.39% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CP
Covalent Partners Concord, Massachusetts $17.6M AUM 2.91% 1-Year Est. Return